Drug development
AB Science SA develops and tests small-molecule medicines, especially its lead drug candidates built to act on specific biological targets in cancer, inflammatory diseases, and some nervous system disorders. The company...
Decide at what price you'd be comfortable buying and we'll help you stay ready.
AB Science SA is a French biopharmaceutical company that develops medicines aimed at diseases where the immune system, inflammation, or certain cancers play a major role. Its work centers on small-molecule drug candidates, especially mast-cell kinase inhibitors, that are designed to change how a disease progresses rather than just treat symptoms. The company does not sell a broad portfolio of commercial drugs; it focuses on research, clinical testing, and regulatory development of a few lead compounds.
The company makes money primarily by advancing these drug candidates through the development process and, if a product is approved, through future drug sales or licensing agreements. Its main customers are not consumers today but doctors, hospitals, and pharmaceutical partners in the markets where its medicines may eventually be used. Because it is a drug developer, its value depends heavily on clinical data, regulatory decisions, and partnerships that can support later-stage development and commercialization.
What makes AB Science different is its narrow focus on a specific drug mechanism and on hard-to-treat conditions such as inflammatory diseases, neurodegenerative disorders, and certain cancers. That puts it in the high-risk, high-reward part of biotech, where scientific progress and trial results matter more than manufacturing scale or a large sales force. It acts as an originator of drug candidates rather than a traditional drug seller.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more